Literature DB >> 31730557

Response to Comment on "Surgery Improves Survival After Neoadjuvant Therapy for Borderline and Locally Advanced Pancreatic Cancer".

Elena Rangelova1, Nicola Orsini, Marco Del Chiaro.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31730557     DOI: 10.1097/SLA.0000000000003418

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  4 in total

1.  Landmark Series: Neoadjuvant Treatment in Borderline Resectable Pancreatic Cancer.

Authors:  Jin He; Richard D Schulick; Marco Del Chiaro
Journal:  Ann Surg Oncol       Date:  2021-01-07       Impact factor: 5.344

2.  Surgical Outcomes After Total Pancreatectomy: A High-Volume Center Experience.

Authors:  Zeeshan Ateeb; Poya Ghorbani; Thomas F Stoop; Lianne Scholten; Urban Arnelo; Marc G Besselink; Marco Del Chiaro
Journal:  Ann Surg Oncol       Date:  2020-08-05       Impact factor: 5.344

3.  Prognosis of resected intraductal papillary mucinous neoplasm of the pancreas: using revised 2017 international consensus guidelines.

Authors:  Ji Hye Min; Young Kon Kim; Honsoul Kim; Dong Lk Cha; Soohyun Ahn
Journal:  Abdom Radiol (NY)       Date:  2020-06-24

4.  Robotic-assisted versus open total pancreatectomy: a propensity score-matched study.

Authors:  Yuanchi Weng; Mengmin Chen; Georgios Gemenetzis; Yusheng Shi; Xiayang Ying; Xiaxing Deng; Chenghong Peng; Jiabin Jin; Baiyong Shen
Journal:  Hepatobiliary Surg Nutr       Date:  2020-12       Impact factor: 7.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.